Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism DCN1 inhibitors(Defective cullin neddylation protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H45N5O3S |
InChIKeyHNIUOJXOXQUOMN-LOSJGSFVSA-N |
CAS Registry2247061-09-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chemical and Drug Induced Liver Injury | Preclinical | US | 11 May 2021 |